Mount Sinai Hospital
Tag
Dec 06, 2022
![<strong>‘Seemingly inconsequential’ inherited DNA mutation triggers sixfold increase in brain tumour risk</strong>](https://oicr.on.ca/wp-content/uploads/2022/11/cells-scaled.jpg)
‘Seemingly inconsequential’ inherited DNA mutation triggers sixfold increase in brain tumour risk
Mar 12, 2020
![The complexities of head and neck cancers may be simpler than we thought](https://oicr.on.ca/wp-content/uploads/2020/03/daniel-s.jpg)
The complexities of head and neck cancers may be simpler than we thought
Aug 09, 2017
![Importance of large database of genetic variants reinforced in a new study](https://oicr.on.ca/wp-content/uploads/2017/08/Lerner_Ellis_OICR.jpg)
Importance of large database of genetic variants reinforced in a new study
Mar 16, 2017
![Researchers discover new test that could change the diagnosis and treatment of prostate cancer](https://oicr.on.ca/wp-content/uploads/2017/01/Bourtros_2016.jpg)
Researchers discover new test that could change the diagnosis and treatment of prostate cancer
Feb 10, 2017
![OICR researchers to be part of Cancer Research UK’s Grand Challenge helping to answer cancer’s biggest questions](https://oicr.on.ca/wp-content/uploads/2017/03/tech-dna.jpg)
OICR researchers to be part of Cancer Research UK’s Grand Challenge helping to answer cancer’s biggest questions
Sep 21, 2016
![New partnership brings Toronto researchers together to better understand the molecular origins of breast cancer](https://oicr.on.ca/wp-content/uploads/2016/09/lab-slice.jpg)
New partnership brings Toronto researchers together to better understand the molecular origins of breast cancer
May 01, 2016
![OICR invests in early-stage Ontario oncology drug development](https://oicr.on.ca/wp-content/uploads/2021/10/oicr-abstact-bkg-4.jpg)
OICR invests in early-stage Ontario oncology drug development
Jan 07, 2016
![Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario](https://oicr.on.ca/wp-content/uploads/2021/10/oicr-abstact-bkg-4.jpg)
Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario
Jun 01, 2015
![The Ontario Institute for Cancer Research invests $4.6 million to support pancreatic cancer research](https://oicr.on.ca/wp-content/uploads/2021/10/ohcrn-placeholder.jpg)
The Ontario Institute for Cancer Research invests $4.6 million to support pancreatic cancer research
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.